Development and validation of a RP-HPLC method for the quantitation and dissolution studies of valdecoxib

Acta Farmaceutica Bonaerense

Volumn 25, Issue 1, 2006, Pages 117-122

  Fronza, Marcio ^a   Brum Jr , Liberato ^a   Wrasse, Micheli ^a   Barth, Thiago ^a   Dalmora, Sérgio Luiz ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Dissolution; RP HPLC; Valdecoxib; Validation

Indexed keywords

VALDECOXIB;

ARTICLE; DISSOLUTION; DRUG SOLUBILITY; MEDICAL RESEARCH; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

EID: 33744475381     PISSN: 03262383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Talley, J.J., D.L. Brown, J.S. Carter, M.J. Graneto, C.M. Koboldt, J.L. Masferrer, W.E. Perkins, R.S. Rogers, A.F. Shaffer, Y.Y. Zhang, B.S. Zweifel & K. Seibert (2000) J. Med. Chem. 43: 775-7.
2. Furlanetto, S., F. Maestrelli, S. Orlandini, S. Pinzauti & P. Mura (2003) J. Pharm. Biomed. Anal. 32: 159-65.
3. Ambike, A.A., K.R. Mahadik & A. Paradkar (2004) Int. J. Pharm. 282: 151-62.
4. Shah, V.P., A. Noory, C. Noory, B. McCullough, S. Clarke, R. Everett, H. Naviasky, B.N. Srinivasan, D. Fortman & J.P. Skelly (1995) Int. J. Pharm. 125: 99-106.
5. Zhang, J.Y., D.M. Fast & A.P. Breau (2003) J. Pharm. Biomed. Anal. 33: 61-72.
6. Sane, R.T., S. Menon, A.Y. Deshpande & A. Jain (2005) Chromatographia 61: 137-41.
7. Ramakrishna, N.V.S., K.N. Vishwottam, S. Wishu & M. Koteshwara (2004) J. Chromatogr. B 802: 271-5.
8. Fitzgerald, G.A. (2004) N. Engl. J. Med. 351: 709-11.
9. Reddy, L.R. & E.J. Corey (2005) Tetrahedron Lett. 46: 927-9.
10. International Conference on Harmonisation (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use, Validation of Analytical Procedures: Methodology (ICH-Q2B), November, 1996, 1-8.
11. Moore, J.W. & H.H. Planner (1996) Pharm. Technol. 20: 64-74.
12. FDA 1997a, Center for Drug Evaluation and Research, Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, August 1997.